BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 33584662)

  • 1. Complement Activation in Kidneys of Patients With COVID-19.
    Pfister F; Vonbrunn E; Ries T; Jäck HM; Überla K; Lochnit G; Sheriff A; Herrmann M; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2020; 11():594849. PubMed ID: 33584662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement Activation
    Niederreiter J; Eck C; Ries T; Hartmann A; Märkl B; Büttner-Herold M; Amann K; Daniel C
    Front Immunol; 2022; 13():835156. PubMed ID: 35237273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Early Complement Activation in Renal Transplantation Associated with Later Graft Outcome?
    Bobka S; Ebert N; Koertvely E; Jacobi J; Wiesener M; Büttner-Herold M; Amann K; Daniel C
    Kidney Blood Press Res; 2018; 43(5):1488-1504. PubMed ID: 30286468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.
    Endo M; Ohi H; Ohsawa I; Fujita T; Matsushita M; Fujita T
    Nephrol Dial Transplant; 1998 Aug; 13(8):1984-90. PubMed ID: 9719152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alternative pathway of complement activation may be involved in the renal damage of human anti-glomerular basement membrane disease.
    Ma R; Cui Z; Hu SY; Jia XY; Yang R; Zheng X; Ao J; Liu G; Liao YH; Zhao MH
    PLoS One; 2014; 9(3):e91250. PubMed ID: 24658070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in early protocol kidney graft biopsies after living-donor transplantation.
    Sund S; Hovig T; Reisaeter AV; Scott H; Bentdal Ø; Mollnes TE
    Transplantation; 2003 Apr; 75(8):1204-13. PubMed ID: 12717204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
    Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
    Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
    Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
    Front Immunol; 2021; 12():714511. PubMed ID: 34290717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19.
    Laurence J; Mulvey JJ; Seshadri M; Racanelli A; Harp J; Schenck EJ; Zappetti D; Horn EM; Magro CM
    Clin Immunol; 2020 Oct; 219():108555. PubMed ID: 32771488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-Organ Complement Deposition on Vascular Endothelium in COVID-19 Patients.
    Macor P; Durigutto P; Mangogna A; Bussani R; De Maso L; D'Errico S; Zanon M; Pozzi N; Meroni PL; Tedesco F
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney.
    Tiller G; Lammerts RGM; Karijosemito JJ; Alkaff FF; Diepstra A; Pol RA; Meter-Arkema AH; Seelen MA; van den Heuvel MC; Hepkema BG; Daha MR; van den Born J; Berger SP
    Front Immunol; 2022; 13():845301. PubMed ID: 35493506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
    Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
    J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition.
    Yu J; Yuan X; Chen H; Chaturvedi S; Braunstein EM; Brodsky RA
    Blood; 2020 Oct; 136(18):2080-2089. PubMed ID: 32877502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
    Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated Nephropathy Includes Tubular Necrosis and Capillary Congestion, with Evidence of SARS-CoV-2 in the Nephron.
    Bouquegneau A; Erpicum P; Grosch S; Habran L; Hougrand O; Huart J; Krzesinski JM; Misset B; Hayette MP; Delvenne P; Bovy C; Kylies D; Huber TB; Puelles VG; Delanaye P; Jouret F
    Kidney360; 2021 Apr; 2(4):639-652. PubMed ID: 35373054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases.
    Magro C; Mulvey JJ; Berlin D; Nuovo G; Salvatore S; Harp J; Baxter-Stoltzfus A; Laurence J
    Transl Res; 2020 Jun; 220():1-13. PubMed ID: 32299776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis.
    Hisano S; Matsushita M; Fujita T; Iwasaki H
    Am J Kidney Dis; 2005 Feb; 45(2):295-302. PubMed ID: 15685507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement Alternative and Mannose-Binding Lectin Pathway Activation Is Associated With COVID-19 Mortality.
    Defendi F; Leroy C; Epaulard O; Clavarino G; Vilotitch A; Le Marechal M; Jacob MC; Raskovalova T; Pernollet M; Le Gouellec A; Bosson JL; Poignard P; Roustit M; Thielens N; Dumestre-Pérard C; Cesbron JY
    Front Immunol; 2021; 12():742446. PubMed ID: 34567008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection.
    Diao B; Wang C; Wang R; Feng Z; Zhang J; Yang H; Tan Y; Wang H; Wang C; Liu L; Liu Y; Liu Y; Wang G; Yuan Z; Hou X; Ren L; Wu Y; Chen Y
    Nat Commun; 2021 May; 12(1):2506. PubMed ID: 33947851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients.
    Barratt-Due A; Pettersen K; Børresdatter-Dahl T; Holter JC; Grønli RH; Dyrhol-Riise AM; Lerum TV; Holten AR; Tonby K; Trøseid M; Skjønsberg OH; Granerud BK; Heggelund L; Kildal AB; Schjalm C; Aaløkken TM; Aukrust P; Ueland T; Mollnes TE; Halvorsen B;
    J Intern Med; 2024 Jul; 296(1):80-92. PubMed ID: 38539241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.